Interview Questions for Ida Sim
Your work with JupyterHealth is pioneering the secure collection and computation of health data from various sources. Could you share how JupyterHealth is currently being implemented in real-world healthcare
Interview Questions for Victor E. Velculescu
1. Integration of Liquid Biopsies:
“Given the rapid advancements in liquid biopsy technologies, including your development of DELFI, how do you envision their integration into routine clinical practice? Considering the current limitations, what
Interview Questions for Nicola Aceto
1. Your research has significantly advanced the understanding of circulating tumor cell (CTC) clusters in the bloodstream. Can you elaborate on the mechanisms that promote the formation of these clusters
Just Published: Groundbreaking AI Model for Cancer Diagnosis by Dr. Isaac Kohane – More at PMWC 2025
Dr. Isaac Kohane and his team have just published in Nature a groundbreaking research in cancer diagnosis using AI, introducing a new model that significantly outperforms current methods. This foundation model for clinical histopathology, trained on over 60,000 pathology slides and validated across 24 hospitals, sets a new standard for cancer diagnosis and prognosis.
Interview Questions for Julie Louise Gerberding
Q1: Public-private partnerships have been instrumental in recent advancements in medical research. Can you…
Interview Questions for Brad Spellberg
Your work on a broad-spectrum vaccine represents a significant innovation in preventing healthcare-associated infections. Can you delve into the latest advancements in its development and explain how this vaccine leverages innate immunity to offer protec
Interview Questions for Isaac Kohane
In your pioneering work, how have you managed to seamlessly integrate EHR data and advanced data science techniques to develop predictive models that personalize treatment strategies for patients with complex health conditions?
Heidi Rehm interview
We are now more than a decade into precision oncology medicine. While we could demonstrate success, we are still struggling with not curing enough patients from devastating cancers.
